Drug metabolism and pharmacokinetics

New lab-grown organ models for drug testing focused on organs that process medicines

Updated

Abstract

Microphysiological Systems (MPS) may provide high physiological relevance for drug discovery and pharmacokinetic studies.

  • MPS technology includes organoids and organ-on-a-chip (OoC) systems, which simulate organ function.
  • Organoids are formed from 3D cell aggregates, while OoCs utilize microfluidic platforms to replicate in vivo environments.
  • Current challenges exist in making MPS reliable alternatives to animal testing.
  • MPS technology is not yet fully comparable to in vivo systems.
  • Advancements may be supported by in silico methods, automation, and AI approaches.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free